Investor Presentaiton slide image

Investor Presentaiton

19 Sales by Indications FY2017 Others FY2016 Infectious 12% Others 12% CNS 12% 12% Oncology CNS 66% 10% Oncology 76% ScinoPharm
View entire presentation